J9256 Injection, nipocalimab-aahu, 3 milligrams
Also known as: nipocalimab, Fabhalta
Intravenous injection of nipocalimab-aahu, a monoclonal antibody targeting neonatal Fc receptor, dosed per 3 milligrams.
In Plain Language
antibody-reducing immunotherapy; antibody-mediated disease therapy
Clinical Context
Used for generalized myasthenia gravis and other antibody-mediated autoimmune conditions.
RVU Information
CPT J9256 does not have a physician work RVU assigned by CMS. This is typical for supply, drug, and equipment codes — reimbursement is based on Average Sales Price (ASP), fee schedules, or payer contracts rather than the RVU system.
Billing & Documentation
J-codes represent drugs administered by a healthcare provider (not self-administered). Documentation must include the drug name, dosage, route of administration, and medical necessity. Most payers require the National Drug Code (NDC) on the claim. Bill the appropriate administration code (96365-96379) in addition to the drug code.
Specialties
Frequently Asked Questions
What is CPT code J9256?
CPT J9256 (Injection, nipocalimab-aahu, 3 milligrams) is a J Codes (Drugs) code. Intravenous injection of nipocalimab-aahu, a monoclonal antibody targeting neonatal Fc receptor, dosed per 3 milligrams.
How is J9256 administered?
CPT J9256 is administered by a healthcare provider, typically via injection or infusion. Used for generalized myasthenia gravis and other antibody-mediated autoimmune conditions. It is used by Neurology, Immunology.
When is CPT J9256 used?
Used for generalized myasthenia gravis and other antibody-mediated autoimmune conditions.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.